Trending stocks

Empire Co Ltd EBITDA jumped on 61.4% in 2015 and Revenue jumped on 14.2%

24.06.2015 • About Empire Co Ltd ($EMP.A) • By InTwits

Empire Co Ltd reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • EBITDA Margin is relatively stable: 5.1% in FY2015 vs. 3.6% in FY2014 vs. 5.4% in FY2011
  • Empire Co Ltd has low CAPEX intensity: 5 year average CAPEX/Revenue was 3.0%. At the same time it's in pair with industry average of 4.9%.
  • CAPEX is quite volatile: 7,273 in 2015, 10,524 in 2014, 8,235 in 2013, 5,194 in 2012, 3,508 in 2011
  • The company has business model with low profitability: ROIC is at 8.4%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Empire Co Ltd ($EMP.A) key annual financial indicators

mln. CAD201120122013201420152015/2014
P&L
Revenue15,95716,24917,40120,95823,92914.2%
Gross Profit3,9804,0294,0755,0165,96218.8%
SG&A3,5393,5773,6004,7875,40412.9%
EBITDA8638779337591,22561.4%
Net Income40133938023541978.0%
Balance Sheet
Cash616510455429296-31.1%
Short Term Debt492425421854-75.3%
Long Term Debt1,0908899163,2822,230-32.0%
Cash flow
Capex552603532563497-11.7%
Ratios
Revenue growth2.8%1.8%7.1%20.4%14.2%
EBITDA growth4.9%1.6%6.4%-18.6%61.4%
Gross Margin24.9%24.8%23.4%23.9%24.9%1.0%
EBITDA Margin5.4%5.4%5.4%3.6%5.1%1.5%
Net Income Margin2.5%2.1%2.2%1.1%1.8%0.6%
SG&A, % of revenue22.2%22.0%20.7%22.8%22.6%-0.3%
CAPEX, % of revenue3.5%3.7%3.1%2.7%2.1%-0.6%
ROIC11.8%11.6%11.9%4.6%8.4%3.8%
ROE13.1%10.3%10.7%5.0%7.2%2.2%
Net Debt/EBITDA0.6x0.7x0.6x4.0x1.6x-2.4x

Revenue and profitability


Empire Co Ltd's Revenue jumped on 14.2% in FY2015. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin increased slightly on 0.96 pp from 4.2% to 5.1% in FY2015.

Gross Margin increased slightly on 0.98 pp from 23.9% to 24.9% in FY2015. SG&A as a % of Revenue showed almost no change in FY2015.

Net Income marign increased slightly on 0.63 pp from 1.1% to 1.8% in FY2015.

Capital expenditures (CAPEX) and working capital investments


Empire Co Ltd's CAPEX/Revenue was 2.1% in FY2015. CAPEX/Revenue decreased slightly on 1.6 pp from 3.7% in FY2012 to 2.1% in FY2015. Average CAPEX/Revenue for the last three years was 2.6%.

Return on investment


The company operates at low ROIC (8.43%) and ROE (7.17%). ROIC increased on 3.8 pp from 4.6% to 8.4% in FY2015. ROE increased on 2.2 pp from 5.0% to 7.2% in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 1.6x and Debt / EBITDA is 1.9x. Net Debt / EBITDA dropped on 2.4x from 4.0x to 1.6x in FY2015. Debt dropped on 34.7% in FY2015 while cash dropped on 31.1% in FY2015.

Appendix 1: Peers in Consumer, Non-cyclical


Below we provide Empire Co Ltd benchmarking against other companies in Consumer, Non-cyclical industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)43.8%-38.8%-72.9%218,969.1%
Cardiome Pharma Corp ($COM)-97.7%-47.6%471.7%566.0%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
Concordia Healthcare Corp ($CXR)159.5%
 
Median (85 companies)11.5%8.7%6.0%12.2%5.6%
Empire Co Ltd ($EMP.A)1.8%7.1%20.4%14.2%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (73 companies)35.4%37.4%36.1%35.6%28.3%
Empire Co Ltd ($EMP.A)24.9%24.8%23.4%23.9%24.9%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (84 companies)8.2%8.5%9.0%10.8%10.3%
Empire Co Ltd ($EMP.A)5.4%5.4%5.4%3.6%5.1%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%
 
Median (85 companies)2.3%2.6%2.4%2.4%4.2%
Empire Co Ltd ($EMP.A)3.5%3.7%3.1%2.7%2.1%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (85 companies)7.4%6.7%6.7%7.8%8.5%
Empire Co Ltd ($EMP.A)11.8%11.6%11.9%4.6%8.4%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x
 
Median (69 companies)1.9x2.8x2.2x2.7x1.5x
Empire Co Ltd ($EMP.A)0.6x0.7x0.6x4.0x1.6x